Skip to main content

Table 4 Treatments and outcome of the 61 BD patients with BCS reported in literature

From: Behcet’s disease in budd-chiari syndrome

Date of publication/authors Number of patients Anti-coagulation Cortico-steroids Immuno-suppressive therapy Surgery Endovascular treatment Outcome Follow up (months)
1980/ [11] 1 0 0 0 0 0 death 4
1996/ [20] 1 0 0 0 1(thrombectomy) 0 death During surgery
2000/ [23] 1 0 0 0 0 0 favourable 180
1983/ [13] 1 T 0 0 0 0 favourable 72
No treatment 4 0 (T, n =1) 0 0 1 thrombectomy 0 Death n = 2 (50%)  
1985/ [14] 1 0 1 1 0 0 favourable 24
2002/ [24] 1 0 1 1 0 0 death 3
2007/ [28] 1 0 1 0 0 thrombolysis (failure) death ND
2007/ [29] 3 0 3 3 0 0 death (n = 2) favourable (n = 1) 7;7;6
No ATCG 6 0 6 5 0 0 Death n = 4 (67%)  
1983/ [12] 1 1 0 0 1(shunt) 0 death 1
1986/ [15] 1 1 0 0 0 1 (stent) favourable 36
1991/ [18] 1 1 0 0 0 0 death 1.25
1990/ [17] 1 1 0 0 0 0 favourable 24
2008/ [30] 1 1 0 0 0 0 death ND
ATCG alone 5 5 0 0 1 1 Death n = 3 (60%)  
1990/ [17] 3 3 (T, n = 1) 2 1 2 (shunt) 0 death (n = 1) 30;4;4
2002/ [25] 1 1 1 0 1 0 relapse (n = 1) 60
2004/ [26] 1 1 1 1 0 dilatation and stent favourable 0.25
2007/ [27] 4 4 4 4 0 0 death (n = 1) 1;96;48;36
2008/ [30] 6 6 6 2 0 0 favourable (n = 6) 43
2011/ [31] 1 1 1 1 0 0 favourable 1
2011/ [32] 1 1 1 1 0 0 alive 1.5
ATCG and IS 17 17 16 10 3 1 Death n = 2 (12%)  
TOTAL 32 ATC 22 (69%) 22 (69%) 15 (47%) 5 (16%) 3 (9%) 12 (38%) 29.7 months
   Thrombolysis 2 (6%)       
  1. Abbreviations: ATC Anticoagulation, IS Immunosuppressants, ND No determined, PT Prothrombin time, T Thrombolysis.